Jones Financial Companies
ADMA icon

Jones Financial Companies’s ADMA Biologics ADMA Stock Holding History

Jones Financial Companies’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.7K Buy
3,392
+556
+20% +$5.07K ﹤0.01% 3335
2026
Q1 		$26.2K Sell
2,836
-3,603
-56% -$56.9K ﹤0.01% 3188
2025
Q4 		$117K Buy
6,439
+4,129
+179% +$69.6K ﹤0.01% 2153
2025
Q3 		$36.1K Sell
2,310
-1,571
-40% -$26.9K ﹤0.01% 2517
2025
Q2 		$70.5K Buy
3,881
+422
+12% +$8.61K ﹤0.01% 2086
2025
Q1 		$70.1K Sell
3,459
-2,274
-40% -$39.3K ﹤0.01% 1922
2024
Q4 		$98.3K Buy
5,733
+4,312
+303% +$81.1K ﹤0.01% 1632
2024
Q3 		$27.5K Buy
+1,421
New +$22.1K ﹤0.01% 1847

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jones Financial Companies's ADMA Position: Q2 2026 in Review

Jones Financial Companies increased its ADMA Biologics (ADMA) stake by 20% in Q2 2026, buying an estimated $5.07K and bringing the position to 3,392 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3335.

Jones Financial Companies first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $117K in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Jones Financial Companies held 3,392 shares of ADMA Biologics worth $29.7K as of Q2 2026.
  • Jones Financial Companies bought 556 ADMA Biologics shares in Q2 2026, an estimated $5.07K.
  • ADMA Biologics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3335 holding.
  • Jones Financial Companies first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's ADMA Biologics position peaked at $117K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.